Medpace Holdings Other Operating Income or Expenses 2014-2026 | MEDP
Medpace Holdings annual/quarterly other operating income or expenses history and growth rate from 2014 to 2026. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
- Medpace Holdings other operating income or expenses for the quarter ending March 31, 2026 were $-0.312B, a 54.15% increase year-over-year.
- Medpace Holdings other operating income or expenses for the twelve months ending March 31, 2026 were $-1.147B, a 45.45% increase year-over-year.
- Medpace Holdings annual other operating income or expenses for 2025 were $-1.037B, a 34.62% increase from 2024.
- Medpace Holdings annual other operating income or expenses for 2024 were $-0.771B, a 6.58% increase from 2023.
- Medpace Holdings annual other operating income or expenses for 2023 were $-0.723B, a 46.77% increase from 2022.
|
Medpace Holdings Annual Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2025 | $-1,037 |
| 2024 | $-771 |
| 2023 | $-723 |
| 2022 | $-493 |
| 2021 | $-373 |
| 2020 | $-293 |
| 2019 | $-294 |
| 2018 | $-237 |
| 2017 | $-50 |
| 2016 | $-51 |
| 2015 | $-39 |
| 2014 | $-58 |
| 2013 | $-29 |
|
Medpace Holdings Quarterly Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2026-03-31 | $-312 |
| 2025-12-31 | $-321 |
| 2025-09-30 | $-277 |
| 2025-06-30 | $-237 |
| 2025-03-31 | $-202 |
| 2024-12-31 | $-191 |
| 2024-09-30 | $-193 |
| 2024-06-30 | $-203 |
| 2024-03-31 | $-184 |
| 2023-12-31 | $-197 |
| 2023-09-30 | $-195 |
| 2023-06-30 | $-178 |
| 2023-03-31 | $-153 |
| 2022-12-31 | $-138 |
| 2022-09-30 | $-128 |
| 2022-06-30 | $-120 |
| 2022-03-31 | $-107 |
| 2021-12-31 | $-102 |
| 2021-09-30 | $-96 |
| 2021-06-30 | $-95 |
| 2021-03-31 | $-80 |
| 2020-12-31 | $-85 |
| 2020-09-30 | $-69 |
| 2020-06-30 | $-62 |
| 2020-03-31 | $-77 |
| 2019-12-31 | $-82 |
| 2019-09-30 | $-71 |
| 2019-06-30 | $-71 |
| 2019-03-31 | $-71 |
| 2018-12-31 | $-63 |
| 2018-09-30 | $-61 |
| 2018-06-30 | $-55 |
| 2018-03-31 | $-57 |
| 2017-12-31 | $-13 |
| 2017-09-30 | $-12 |
| 2017-06-30 | $-12 |
| 2017-03-31 | $-13 |
| 2016-12-31 | $-13 |
| 2016-09-30 | $-13 |
| 2016-06-30 | $-13 |
| 2016-03-31 | $-12 |
| 2015-12-31 | |
| 2015-09-30 | $-10 |
| 2014-12-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.094B | $2.530B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Cencora (COR) | United States | $62.409B | 19.63 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |